Your browser doesn't support javascript.
loading
Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy.
Gozzi, Gustavo J; Gonzalez, Daniel; Boudesco, Christophe; Dias, Alexandre M M; Gotthard, Guillaume; Uyanik, Burhan; Dondaine, Lucile; Marcion, Guillaume; Hermetet, François; Denis, Camille; Hardy, Laurianne; Suzanne, Peggy; Douhard, Romain; Jego, Gaetan; Dubrez, Laurence; Demidov, Oleg N; Neiers, Fabrice; Briand, Loïc; Sopková-de Oliveira Santos, Jana; Voisin-Chiret, Anne-Sophie; Garrido, Carmen.
Afiliação
  • Gozzi GJ; INSERM UMR1231, Laboratory of Excellence LipSTIC and label Ligue Nationale contre le Cancer, Dijon, France.
  • Gonzalez D; University of Burgundy Franche-Comté, Dijon, France.
  • Boudesco C; INSERM UMR1231, Laboratory of Excellence LipSTIC and label Ligue Nationale contre le Cancer, Dijon, France.
  • Dias AMM; University of Burgundy Franche-Comté, Dijon, France.
  • Gotthard G; INSERM UMR1231, Laboratory of Excellence LipSTIC and label Ligue Nationale contre le Cancer, Dijon, France.
  • Uyanik B; University of Burgundy Franche-Comté, Dijon, France.
  • Dondaine L; INSERM UMR1231, Laboratory of Excellence LipSTIC and label Ligue Nationale contre le Cancer, Dijon, France.
  • Marcion G; University of Burgundy Franche-Comté, Dijon, France.
  • Hermetet F; European Synchrotron Radiation Facility, F-38043, Grenoble, France.
  • Denis C; INSERM UMR1231, Laboratory of Excellence LipSTIC and label Ligue Nationale contre le Cancer, Dijon, France.
  • Hardy L; University of Burgundy Franche-Comté, Dijon, France.
  • Suzanne P; INSERM UMR1231, Laboratory of Excellence LipSTIC and label Ligue Nationale contre le Cancer, Dijon, France.
  • Douhard R; University of Burgundy Franche-Comté, Dijon, France.
  • Jego G; INSERM UMR1231, Laboratory of Excellence LipSTIC and label Ligue Nationale contre le Cancer, Dijon, France.
  • Dubrez L; University of Burgundy Franche-Comté, Dijon, France.
  • Demidov ON; INSERM UMR1231, Laboratory of Excellence LipSTIC and label Ligue Nationale contre le Cancer, Dijon, France.
  • Neiers F; University of Burgundy Franche-Comté, Dijon, France.
  • Briand L; Normandie Université, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Boulevard Becquerel, 14032, Caen, France.
  • Sopková-de Oliveira Santos J; Normandie Université, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Boulevard Becquerel, 14032, Caen, France.
  • Voisin-Chiret AS; Normandie Université, UNICAEN, EA 4258 CERMN (Centre d'Etudes et de Recherche sur le Médicament de Normandie) - FR CNRS INC3M, Boulevard Becquerel, 14032, Caen, France.
  • Garrido C; INSERM UMR1231, Laboratory of Excellence LipSTIC and label Ligue Nationale contre le Cancer, Dijon, France.
Cell Death Differ ; 27(1): 117-129, 2020 01.
Article em En | MEDLINE | ID: mdl-31068676
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas de Choque Térmico HSP110 / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Death Differ Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas de Choque Térmico HSP110 / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Death Differ Ano de publicação: 2020 Tipo de documento: Article